Literature DB >> 1385520

Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells.

D E Epperson1, D Arnold, T Spies, P Cresswell, J S Pober, D R Johnson.   

Abstract

Transporter in Ag processing-1 (TAP-1, previously called PSF-1 or Ring-4) is an MHC-encoded gene product that is required for efficient association of intracellular peptide Ag with nascent HLA class I H chain and beta 2-microglobulin, thereby permitting assembly and normal surface expression of the class I molecules. TAP-1 is thought to function as a component of a transmembrane pump, that transports cytoplasmically-derived peptides into the lumen of the endoplasmic reticulum where class I molecules assemble. Synthesis and expression of HLA class I molecules is increased in human endothelial cells by IFN-beta, IFN-gamma, and TNF. We report these same cytokines increase TAP-1 expression. As with class I, TAP-1 is also synergistically increased by combinations of TNF with IFN. Interestingly, cytokine-induced increases in TAP-1 mRNA are markedly more rapid than increases in class I mRNA. This rapid increase in TAP-1 mRNA is reflected in a rapid increase in TAP-1 protein. These results demonstrate that TAP-1 synthesis and class I synthesis are regulated in parallel. The rapidity of the cytokine response of TAP-1 compared to class I further suggests that the constitutive level of TAP-1 expression in endothelial cells is not sufficient to support inducible increases in class I expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Authors:  Juergen Bukur; Felix Herrmann; Diana Handke; Christian Recktenwald; Barbara Seliger
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 2.  Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.

Authors:  George Makedonas; Michael R Betts
Journal:  Springer Semin Immunopathol       Date:  2006-08-25

3.  Cloning and functional analyses of the mouse tapasin promoter.

Authors:  Felix Herrmann; John Trowsdale; Christoph Huber; Barbara Seliger
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

Review 4.  Cytokine research: the interferon paradigm.

Authors:  A Morris; I Zvetkova
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

5.  Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.

Authors:  A Vambutas; V R Bonagura; B M Steinberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

6.  Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.

Authors:  Melanie E Dobbs; Jane E Strasser; Chin-Fun Chu; Claudia Chalk; Gregg N Milligan
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Chicken TAP genes differ from their human orthologues in locus organisation, size, sequence features and polymorphism.

Authors:  Brian A Walker; Andrew van Hateren; Sarah Milne; Stephan Beck; Jim Kaufman
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

Review 8.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

9.  Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells.

Authors:  Scott A Gerber; Bogdan Yatsula; Cheryl L Maier; Timothy J Sadler; Laurence W Whittaker; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-02       Impact factor: 8.311

Review 10.  CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis.

Authors:  Korey R Demers; Morgan A Reuter; Michael R Betts
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.